INTRODUCTION
The utilization of endogenously synthesized triacylglycerol by extrahepatic tissues is facilitated by the assembly and secretion of VLDL by the liver. An important precursor of hepatic triacylglycerol is fatty acid synthesized de novo by the liver (Boogaerts et al., 1984; Azain et al., 1985) . However, the relationship between the regulation of fatty acid synthesis and that of VLDL triacylglycerol secretion is obscure, and the rates at which these two processes operate do not always change in parallel with each other. For instance, insulin, which is generally considered to stimulate fatty acid synthesis de novo (Geelen et al., 1980) , has a direct inhibitory effect on hepatic VLDL secretion, at least in the short term (Durrington et al., 1982; Patsch et al., 1983; Pullinger & Gibbons, 1985; Mangiapane & Brindley, 1986) . The inhibitory effect becomes less pronounced after longer periods of insulin treatment, and this has been ascribed to insulin resistance resulting from down-regulation of the insulin receptor (Patsch et al., 1986) . The role of glucocorticoids in potentiating the effect of insulin on hepatic lipid metabolism (Amatruda et al., 1983) and in promoting insulin resistance (Caro & Amatruda, 1982) suggests that this type of hormone may be involved in the detailed regulation of VLDL secretion. Support for this concept has subsequently been forthcoming (Mangiapane & Brindley, 1986) . One of the objectives of the present work was therefore to define the precise effects of insulin on VLDL triacylglycerol secretion in terms of the duration of treatment, age of the culture and the role of the synthetic glucocorticoid dexamethasone.
In contrast with the opposing short-term effects of insulin on fatty acid synthesis and VLDL secretion, short-term (0-3 h) stimulation in vitro of fatty acid synthesis de novo by increasing the availability of intermediary metabolites such as lactate and pyruvate (Salmon et al., 1974; Boyd et al., 1981; Gibbons et al., 1984) increased the secretion of VLDL triacylglycerol by isolated hepatocytes (Pullinger & Gibbons, 1985; Gibbons & Pullinger, 1987) . A second objective of the present work was to examine the longer-term effects of lactate and pyruvate and to determine whether, and to what extent, these effects were modified by insulin and dexamethasone.
Finally, little is known of the extent to which changes in the secretion ofVLDL triacylglycerol are accompanied by changes in the secretion of esterified and non-esterified cholesterol. Differential secretion of the lipid components of VLDL may affect its metabolism by lipoprotein lipase (Demel & Jackson, 1985) and its subsequent clearance from the plasma as intermediate-and low-density lipoprotein by cell-surface receptors (Goldstein & Brown, 1984; Lopes-Virella et al., 1982; Witztum et al., 1985) . In view of the potential importance of these structural changes in determining the steady-state plasma lipoprotein concentration, we wished to investigate the effects of the above hormones and lipogenic precursors on the secretion of VLDL esterified and nonesterified cholesterol. (Seglen, 1976) as described previously (Pullinger & Gibbons, 1983 . In the present experiments, however, the Krebs-Henseleit (1932) perfusion buffer and the collagenase were sterilized by passage through Millex-GS Filters (Millipore S. A., Molsheim, France). The hepatocytes were finally suspended in Waymouth's medium MB752/1 (1.0 x 106 cells/ml) containing glutamine (3.4 mM), serine (0.5 mM), alanine (0.4 mM), penicillin (200 units/ml), streptomycin (200 ,tg/ml) and newborn-calf serum (10 %). (Juul & Jones, 1982) . Similar concentrations of insulin to that used here provoked maximal inhibition of labelled VLDL-triacylglycerol secretion (Durrington et al., 1982) . Isolation of VLDL and measurement of cholesterol (esterified and non-esterified) and triacylglycerol At the end of each 24 h period, the medium from two identically treated dishes was combined, the density was adjusted to 1.006 g/ml, and NaN3 was added to give a concentration of 0.1 g/litre. The supernatant was centrifuged at 20000 g for 20 min, followed by centrifugation at 40000 rev./min in a Beckman SW-50.1 rotor for 18 h. The floating fraction, of d < 1.006, was obtained by tube slicing. A portion of the VLDL-containing fraction was used for extraction of the total lipids (Folch et al., 1957) . The total lipid fraction was dissolved in ethanol (0.3 ml) and the triacylglycerol content was determined by the glycerol-3-phosphate oxidase method (Trinder, 1969) . The materials for this assay were obtained as a kit supplied by Boehringer Corp. (London). Total (esterified and non-esterified) cholesterol and non-esterified cholesterol were determined by a modification of a method described previously (Pullinger & Gibbons, 1985) . In the present work the derived cholest-4-en-3-one was isolated directly by chromatography of the enzyme-treated VLDL fraction on Whatman (Maidstone, Kent, U.K.) LK5D thin-layer silica-gel plates. The chromatoplate was developed with chloroform, and the heptafluorobutyryl enol ester of cholest-4-en-3-one was prepared and assayed by gas chromatography (Pullinger & Gibbons, 1985) . Determination of cellular protein concentration and rates of protein synthesis At the beginning of each 24 h incubation period, [3H]-leucine (5 ,uCi) was added to the cells to give a final specific radioactivity of 0.67 ,uCi/,umol. After incubation, the medium was removed for isolation of the VLDL (see above) and ice-cold Dulbecco's phosphate-buffered saline (140 mM-NaCl /2.7 mM-KCl / 8.0 mM-Na2HPO4 / 0.9 mM-CaCl2/ 1.5 mM-KH2PO4/0.6 mM-MgCl2) was added to the cells. The cells were detached from the plate with a rubber 'policeman' and transferred to a centrifuge tube. The dish was washed with a further 2.0 ml of phosphate-buffered saline, and the cells were obtained by centrifugation at 500 g for 5 min. The supernatant was removed, and the cells were sonicated (MSE M-126 sonicator, 10 s at 6 ,im) after suspension in 0.5 ml of phosphate-buffered saline. A sample of the sonicated material was removed for determination of protein mass (Lowry et al., 1951) . Another sample was transferred to a filter paper soaked with a solution of trichloroacetic acid (5 %, v/v). The filter paper was washed with 5 % trichloroacetic acid (1.0 ml), followed by ethanol (1.0 ml), and the precipitated protein was assayed for radioactivity by scintillation counting.
Materials
All culture-media components were obtained from Gibco (Paisley, Scotland, U.K.). Bovine insulin, dexamethasone, pyruvate and lactate were obtained from Sigma (Poole, Dorset, U.K.).
RESULTS

Effect of age of the culture on the secretion of VLDL
In the absence of any hormone or substrate supplement, the rates of secretion of lipids associated with VLDL declined after each successive 24 h incubation period ( Fig. 1) 
VLDL lipid secretion
Hepatocytes were plated into dishes in Waymouth's medium supplemented with serum (10 %) at a concentration of 1.0 x 106 cells/ml. After 4 h, the medium was removed and the monolayer was washed three times with 3.0 ml of serum-free Waymouth's medium; 3.0 ml of the same medium was added to all dishes. The dishes were then divided into three batches, A, B and C, and treated according to Protocols A, B and C respectively, as Short-term effects of dexamethasone, insulin and lipogenic substrates on the secretion of VLDL in older cultures (Protocol B) Insulin again gave rise to a decrease in the secretion of VLDL from these older cultures, and the extent of inhibition was similar to that observed in young cultures ( Table 2 ). The stimulatory effects of dexamethasone, added alone, on the secretion of VLDL triacylglycerol was more pronounced in these cultures. However, the most important difference between these and the younger cultures was the inability of lactate plus pyruvate to sustain an increased rate of VLDL lipid secretion, in the presence of dexamethasone. In the presence of this glucocorticoid, the substrate mixture had no further stimulatory effect, and, in fact, under these conditions there was actually a significant and substantial decline in the rate of triacylglycerol secretion ( Table 1 
At 4 h after plating the hepatocytes, the medium was removed and the monolayer was washed three times with serum-free Waymouth's medium. Then 3.0 ml of the same medium was added, followed by additions of hormones and substrates as indicated. The cells were incubated for 24 h, after which the medium was removed and the VLDL-containing fraction was isolated. The mass of triacylglycerol and of total and non-esterified cholesterol associated with the VLDL was determined. The values represent means+S.E.M. for at least three independent hepatocyte preparations. Values marked *, ** and *** are significantly different from the controls, at P < 0.05, P < 0.01 and P < 0.001 respectively.
Rate of secretion of VLDL lipids (% of control) (Fig. 3) . In the case of triacylglycerol, the inhibitory effect of insulin increased to reach a maximum between 6 and 12 h after its addition to the medium. At this point the cells secreted only 7.9 + 4.1 % of the control value, compared with 57.6+ 13.6% during the previous 6 h period. During the next 12 h period the inhibitory effect was less pronounced (44.2 + 7.7% of control). This represented the beginning of the reversal of the insulin effect, which culminated in a stimulation of triacylglycerol secretion between 24 and 48 h (Table 3) . The response of esterified and non-esterified cholesterol showed a similar pattern to that of triacylglycerol, with a maximal inhibitory effect occurring between 6 h and 12 h after addition of insulin (Fig. 3) . Differential effects of hormones on the secretion of VLDL lipids Although, in general, changes in the rates of secretion of a particular lipid were accompanied by parallel changes in those of the other lipid fractions, this was not always the case. In this respect one of the most striking Table 3 . Longer-term effects of hormones and lipogenic substrates on the secretion of VLDL lipids Monolayers were treated as described in the legend to Table 2 . However, after incubation for 24 h in the presence of the appropriate hormone(s) and/or substrates, the medium was replaced with 3.0 ml of fresh medium and the appropriate additions were made to corresponding dishes. The secretion of VLDL triacylglycerol, total and non-esterified cholesterol into the medium during the next 24 h period was determined. The values represent means + S.E.M. for three independent hepatocyte preparations.
Values marked t and tt are significantly different from the controls, at P < 0.05 and P < 0.01 respectively. examples was the differential effect of insulin on the secretion of esterified and non-esterified cholesterol. For instance, when the inhibitory effect of insulin on VLDL secretion was increasing (i.e. between 0 and 6 h after treatment), although the secretion of total cholesterol declined to 54.4 + 11.1 % of the control value (P < 0.05), there was no significant effect on the secretion of nonesterified cholesterol (87.9 + 26.1 % of control). This discrepancy could be accounted for by a decline in the secretion of esterified cholesterol from 0.29 + 0.05,ug/ mg of cell protein (control) to 0.06 + 0.06,ug/mg in the presence of insulin. There was no significant difference in the rates of secretion of non-esterified cholesterol (1.02 + 0.09 and 0.90 + 0.26,g/mg respectively). When insulin stimulated VLDL triacylglycerol and cholesterol secretion (i.e. during the last 24 h of the 48 h treatment period), the effect tended to be more pronounced on cholesteryl ester [0.96 + 0.21,tg/mg of protein (insulin) versus 0.51 + 0.22 ,ug/mg of protein (control)] than on non-esterified cholesterol (1.70 + 0.43 and 2.00 + 0.95 jig/ mg of protein respectively).
Rate of secretion of VLDL lipids (% of control)
In other cases, a particular treatment produced changes in the rate of secretion of VLDL triacylglycerol, but not of esterified or non-esterified cholesterol, e.g. during the final 24 h of the 48 h treatment with dexamethasone plus insulin plus lactate and pyruvate (Table 3) .
DISCUSSION
Rates of VLDL secretion by cultured hepatocytes: comparison with isolated perfused liver and rates in vivo During the first 24 h after removal of serum from the medium (i.e. 4-28 h after plating), in the absence of added hormones and substrates the rate of VLDL triacylglycerol secretion was 95.1 + 5.3,g/mg of cell protein. This rate was similar to, or somewhat higher than, those quoted by other authors under similar conditions [e.g. 72 ,ug/mg of cell protein (Durrington et al., 1982) ; 60 ,ug/mg of protein (Patsch et al., 1983) ]. Between 24 h and 48 h in culture, the rate of triacylglycerol secretion declined to 46.3 + 2.3 ,ug/mg of protein, a value which compared well with that reported previously for cultures of a similar age [i.e. 27.1 ,ug/mg of cell protein (Davis & Boogaerts, 1982) ]. In the present work, the rates of secretion were considerably higher than any of five previously quoted values for isolated perfused livers (Marsh, 1986) , but were lower than the rate in vivo determined after treatment of intact animals with Triton WR-1339 (Otway & Robinson, 1967; Goh & Heimberg, 1979) . Although the rates of VLDL secretion declined in each subsequent 24 h period (Fig. 1) , the rate of triacylglycerol secretion remained linear during the period 24-48 h after preparation of the cells (Fig. 2) (Salmon et al., 1974; Boyd et al., 1981; Katz & McGarry, 1984; Gibbons et al., 1984) . In freshly isolated hepatocytes, the increase in the rate of fatty acid synthesis de novo which occurs in the presence of these substrates is accompanied by an increase in the rates of secretion of VLDL triacylglycerol and cholesterol (Pullinger & Gibbons, 1985; Gibbons & Pullinger, 1987) . However, in the cultured cells, during the period 4-28 h after plating, the stimulatory effect of these lipogenic precursors on the secretion of triacylglycerol and non-esterified cholesterol only became marked when dexamethasone was simultaneously present. If glucocorticoids are a prerequisite for a positive response to lipogenic precursors, it is possible that, in freshly prepared cells, the intracellular concentration of hormone remains sufficiently high to permit a positive response to lactate plus pyruvate during a 3 h incubation period. In cells cultured for a longer period, the intracellular glucocorticoid concentration probably declines and, under these conditions, lipogenic substrates alone are incapable of stimulating VLDL secretion. The lack of a significant stimulatory effect of the glucocorticoid/substrate combination on cultures older than 28 h possibly reflects the loss of some other mediating factor during this period.
Biphasic effect of insulin on VLDL secretion
The inhibitory effect of insulin on VLDL triacylglycerol and cholesterol secretion increased with time of exposure to reach a maximum between 6 h and 12 h, during which the secretion of VLDL decreased to only 8 % ofthe control value. Between 12 h and 24 h inhibition became less pronounced (Fig. 3) , and after 24 h of insulin treatment VLDL secretion increased (Table 3) . Direct short-term inhibitory effects of insulin on hepatic VLDL secretion have been observed previously (Durrington et al., 1982; Patsch et al., 1983; Pullinger & Gibbons, 1985; Mangiapane & Brindley, 1986) , and are in apparent contrast with the increased hepatic VLDL secretion associated with high plasma insulin concentrations in vivo (Olefsky et al., 1974; Reaven & Greenfield, 1981; Steiner et al., 1984) . The reasons for this discrepancy have been discussed previously (Gibbons, 1986) , and may relate to indirect effects of insulin on extrahepatic metabolism in vivo or to hepatic insulin resistance. A diminution of the inhibitory effect of insulin after 15 h pretreatment with the hormone has been reported, and this has been ascribed to insulin resistance resulting from a down-regulation of the insulin receptor (Patsch et al., 1986) . However, the present results show that this mitigation of the inhibitory response is merely the prelude to an eventual stimulation of VLDL secretion if insulin treatment was continued for a sufficient length of time (i.e. > 24 h). Whether this effect of chronic insulin exposure has any physiological relevance remains to be determined. However, it should be noted that in vivo the liver is normally exposed to a rhythmic fluctuation in the concentration of plasma insulin (Schlierf & Dorow, 1973; Knox et al., 1979; Teidgen & Seitz, 1980) , and this is determined by the cyclical pattern of food intake. Under these conditions the liver would never be exposed to a continuously high concentration of insulin for a sufficiently lengthy period to promote stimulation of VLDL secretion. However, in conditions characterized by chronic hyperinsulinaemia, such as obesity and noninsulin-dependent diabetes, the normal control of VLDL secretion may be over-ridden, resulting in a hypersecretion of hepatic triacylglycerol and cholesterol. Modification of the insulin effect by dexamethasone
The short-term inhibitory effect of insulin on VLDL lipid secretion was mitigated to some extent when dexamethasone was present simultaneously (Table 1) . The ability of dexamethasone to over-ride the inhibitory effect of insulin has also been noted by other authors (Mangiapane & Brindley, 1986) . The stimulation of VLDL secretion by chronic insulin treatment was also modified by dexamethasone (Table 3 ). In view of the apparent importance of insulin resistance in determining the exact response of VLDL secretion, it is possible that glucocorticoids in some way increase insulin resistance, a possibility for which there is some experimental evidence (Caro & Amatruda, 1982) . Differential effect of insulin on the secretion of VLDL lipids Between 0 and 6 h after addition of insulin, although there was a significant decline in the secretion of triacylglycerol and cholesteryl ester, there was no significant change in the secretion of unesterified cholesterol. Nonesterified cholesterol forms part of the polar sheath of the VLDL particle, in contrast with esterified cholesterol and triacylglycerol, which are located in the hydrophobic core. In this respect, Patsch et al. (1983) have shown that the secretion of phospholipid, which also forms part of the outer envelope, is also less sensitive to inhibition by insulin than is that of triacylglycerol. The differential inhibition of the secretion of esterified and non-esterified cholesterol gave rise to a change in the relative proportion of these lipids in the newly secreted VLDL particle. Changes of this type give rise to differences in the rates of transfer of cholesterol between different types of lipoprotein, and may ultimately affect the rate at which lipoprotein cholesterol is cleared from the plasma (Fielding et al., 1982 (Fielding et al., , 1984 .
